Metabolic syndrome markers and risk of hyperglycemia in pregnancy: a cross-sectional cohort study

Registro completo de metadados
MetadadosDescriçãoIdioma
Autor(es): dc.contributorUniversidade Estadual Paulista (Unesp)-
Autor(es): dc.creatorVernini, Joice M. [UNESP]-
Autor(es): dc.creatorNicolosi, Bianca F. [UNESP]-
Autor(es): dc.creatorArantes, Mariana A. [UNESP]-
Autor(es): dc.creatorCosta, Roberto A. [UNESP]-
Autor(es): dc.creatorMagalhães, Claudia G. [UNESP]-
Autor(es): dc.creatorCorrente, José E. [UNESP]-
Autor(es): dc.creatorLima, Silvana A. M. [UNESP]-
Autor(es): dc.creatorRudge, Marilza V. [UNESP]-
Autor(es): dc.creatorCalderon, Iracema M. [UNESP]-
Data de aceite: dc.date.accessioned2022-02-22T00:48:38Z-
Data de disponibilização: dc.date.available2022-02-22T00:48:38Z-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2021-06-25-
Data de envio: dc.date.issued2020-11-30-
Fonte completa do material: dc.identifierhttp://dx.doi.org/10.1038/s41598-020-78099-3-
Fonte completa do material: dc.identifierhttp://hdl.handle.net/11449/206920-
Fonte: dc.identifier.urihttp://educapes.capes.gov.br/handle/11449/206920-
Descrição: dc.descriptionThe aim was to assess the role of Metabolic Syndrome (MetS) diagnostic markers, recommended by three different guidelines, in the prediction of hyperglycemia in pregnancy. This cross-sectional cohort study included 506 non-diabetic women, with a singleton pregnancy, who underwent a diagnostic test for hyperglycemia at 24–28 weeks. Clinical, anthropometric, and laboratory data were obtained. The relationship between MetS markers and the risk of hyperglycemia was evaluated by backward stepwise logistic regression analysis (OR, 95% CI). The limit of statistical significance was 95% (p < 0.05). Triglycerides (TG) ≥ 150 mg/dL, blood pressure (BP) ≥ 130/85 mmHg, fasting glucose (FG) ≥ 100 mg/dL, and waist circumference (WC) > 88 cm were identified as independent risk factors for hyperglycemia in pregnancy. These results might help the selective screening of hyperglycemia in pregnancy.-
Descrição: dc.descriptionFundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)-
Descrição: dc.descriptionConselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)-
Descrição: dc.descriptionGraduate Program in Obstetrics Gynecology and Mastology Botucatu Medical School São Paulo State University/Unesp-
Descrição: dc.descriptionDepartment of Gynecology and Obstetrics Botucatu Medical School São Paulo State University/Unesp-
Descrição: dc.descriptionDepartment of Biostatistics Botucatu Institute of Biosciences São Paulo State University/Unesp-
Descrição: dc.descriptionDepartment of Nursing Botucatu Medical School São Paulo State University/Unesp-
Descrição: dc.descriptionGraduate Program in Obstetrics Gynecology and Mastology Botucatu Medical School São Paulo State University/Unesp-
Descrição: dc.descriptionDepartment of Gynecology and Obstetrics Botucatu Medical School São Paulo State University/Unesp-
Descrição: dc.descriptionDepartment of Biostatistics Botucatu Institute of Biosciences São Paulo State University/Unesp-
Descrição: dc.descriptionDepartment of Nursing Botucatu Medical School São Paulo State University/Unesp-
Descrição: dc.descriptionFAPESP: 12/51257-9-
Descrição: dc.descriptionCNPq: PQ-CNPq #304771/2015-5-
Idioma: dc.languageen-
Relação: dc.relationScientific Reports-
???dc.source???: dc.sourceScopus-
Título: dc.titleMetabolic syndrome markers and risk of hyperglycemia in pregnancy: a cross-sectional cohort study-
Tipo de arquivo: dc.typelivro digital-
Aparece nas coleções:Repositório Institucional - Unesp

Não existem arquivos associados a este item.